Azenta (NASDAQ: AZTA) — Company Overview, News & Financial Data
Azenta specializes in automating processes in life sciences to enhance drug discovery and delivery efficiency.
Azenta
Azenta (NASDAQ:AZTA) specializes in automating and optimizing processes within the life sciences sector. Its broad range of services caters to drug discovery, development, and delivery phases, aiming to enhance efficiency and innovation. Azenta focuses on comprehensive solutions, including sample management, storage, and genomic services, to support research and pharmaceutical entities in accelerating their scientific endeavors. The objective of Azenta is to empower breakthroughs in healthcare and biotechnology through its integrated technology and expertise. With a commitment to advancing life sciences, Azenta continually invests in research and development, seeking to drive the future of automated biostorage and analysis.
Snapshot
Operations
Products and/or services of Azenta
- Life Sciences Solutions - Offers comprehensive sample lifecycle management solutions, focusing on handling, storage, and analysis of biological and chemical samples.
- Genomic Services - Provides advanced DNA sequencing, gene synthesis, and other genomics services to support research and clinical applications.
- Automated Cold Storage Systems - Develops state-of-the-art automated storage solutions for biological specimens at cryogenic temperatures, enhancing sample integrity and accessibility.
- Brokerage Services - Offers specialized transportation and logistics services for sensitive biological materials, ensuring safe and compliant global shipping.
- Bioinformatics Software and Services - Delivers powerful data analysis tools and services for genomic and other biological data, aiding in research and discovery.
- Custom Lab Automation Solutions - Engineers tailored automation systems for laboratories, improving efficiency and accuracy in research and diagnostic workflows.
Azenta executive team
- Martin D. MadausInterim President, CEO & Director
- Lawrence Y. LinExecutive VP & CFO
- Ephraim StarrSenior VP, General Counsel & Corporate Secretary
- Olga PirogovaSenior VP & Chief HR Officer
- Ginger ZhouAdvisor
- Erik J. BelloVice President, Chief Accounting Officer & Principal Accounting Officer
- Michael PauloVP, Chief Information & Digital Officer
- Yvonne PerronVice President of Financial Planning & Analysis and Investor Relations
- William E. Martin IIISenior Vice President & President of Multiomics
- Andrea O'HaraStrategic Technical Specialist of Azenta Life Sciences
Dividend history
Dividends per share paid by Azenta, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2022 | — | — | — | $0.1000 |
| FY2021 | — | — | — | $0.4000 |
| FY2020 | — | — | — | $0.4000 |
| FY2019 | — | — | — | $0.4000 |
| FY2018 | — | — | — | $0.4000 |
Key financials
Reported results for Azenta, in USD.
- Market cap
- 1.8B
- Revenue (TTM)
- 613.8M
- P/E ratio
- —
- EPS (diluted, TTM)
- -2.5
- Dividend yield
- —
- Profit margin
- -20.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 593.8M | -11.3M | -55.8M | |
| 573.4M | -30M | -164.9M | |
| 665.1M | -82.2M | -14.3M | |
| 555.5M | -24M | -429M |